Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.90
-0.52 (-7.01%)
At close: May 15, 2026, 4:00 PM EDT
7.02
+0.12 (1.74%)
After-hours: May 15, 2026, 7:22 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $723.73 million as of May 15, 2026. Its market cap has increased by 6,139.04% in one year.
Market Cap
723.73M
Enterprise Value
544.31M
1-Year Change
6,139.04%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $723.73M, an increase of 1,178.67%. That is a compound annual growth rate of 27.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 723.70M | 104.32% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 792.74M |
| CytomX Therapeutics | 785.91M |
| SpyGlass Pharma | 775.83M |
| Bright Minds Biosciences | 763.26M |
| ARS Pharmaceuticals | 737.31M |
| Eikon Therapeutics | 717.34M |
| Tenax Therapeutics | 705.36M |
| Allogene Therapeutics | 690.31M |